CELU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Celularity Inc (CELU) is not a good buy for a beginner investor with a long-term strategy at this time. The company's financial performance shows significant revenue decline, and there are no strong positive catalysts or trading signals to justify an entry point. Additionally, the lack of recent news, neutral insider and hedge fund activity, and absence of congressional trading data further suggest a lack of immediate upside potential.
The MACD is positive and expanding, indicating a bullish trend. RSI is neutral at 66.467, and moving averages are converging, suggesting indecision in the market. The stock is trading near its resistance levels (R1: 1.314, R2: 1.355), which could limit further upward movement in the short term.
The MACD indicates a bullish trend, and historical candlestick analysis suggests a 100% probability of gains in the next day, week, and month.
Revenue dropped significantly by -43.16% YoY in Q3 2025, and gross margin fell by -64.94% YoY. There is no recent news or significant insider or hedge fund activity. Additionally, no recent congressional trading data is available.
In Q3 2025, revenue dropped to $5.28M (-43.16% YoY), net income improved to -$23.08M (+43.35% YoY), and EPS increased to -0.88 (+20.55% YoY). However, gross margin dropped significantly to 19% (-64.94% YoY), indicating operational challenges.
No recent analyst ratings or price target changes are available for CELU.
